Novartis Aktie
114,80
EUR
-1,30
EUR
-1,12
%
107,96
CHF
+0,48
CHF
+0,45
%
Werbung
Novartis Aktie Analyse
| 19.07.12 | Novartis buy | Sarasin Research | |
| 19.07.12 | Novartis hold | Vontobel Research | |
| 19.07.12 | Novartis hold | Vontobel Research | |
| 19.07.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 18.07.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 17.07.12 | Novartis buy | Deutsche Bank AG | |
| 17.07.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 17.07.12 | Novartis buy | UBS AG | |
|
Werbung
|
|||
| 13.07.12 | Novartis buy | Nomura | |
| 13.07.12 | Novartis kaufen | Fuchsbriefe | |
| 12.07.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 12.07.12 | Novartis outperform | Credit Suisse Group | |
| 12.07.12 | Novartis hold | Vontobel Research | |
| 12.07.12 | Novartis neutral | Citigroup Corp. | |
| 11.07.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 05.07.12 | Novartis buy | Deutsche Bank AG | |
| 28.06.12 | Novartis buy | Deutsche Bank AG | |
| 28.06.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 25.06.12 | Novartis neutral | UBS AG | |
| 25.06.12 | Novartis buy | UBS AG | |
| 22.06.12 | Novartis outperform | Credit Suisse Group | |
| 19.06.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 19.06.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 11.06.12 | Novartis hold | Vontobel Research | |
| 08.06.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 05.06.12 | Novartis hold | Vontobel Research | |
| 04.06.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 04.06.12 | Novartis neutral | Citigroup Corp. | |
| 04.06.12 | Novartis hold | Vontobel Research | |
| 31.05.12 | Novartis buy | Deutsche Bank AG | |
| 30.05.12 | Novartis outperform | Credit Suisse Group | |
| 29.05.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 29.05.12 | Novartis buy | UBS AG | |
| 29.05.12 | Novartis buy | UBS AG | |
| 23.05.12 | Novartis hold | Vontobel Research | |
| 18.05.12 | Novartis hold | Vontobel Research | |
| 17.05.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 10.05.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 04.05.12 | Novartis neutral | Banc of America Securities-Merrill Lynch | |
| 04.05.12 | Novartis buy | UBS AG | |
| 03.05.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 03.05.12 | Novartis hold | Vontobel Research | |
| 30.04.12 | Novartis hold | Vontobel Research | |
| 26.04.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 25.04.12 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 25.04.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 25.04.12 | Novartis hold | Vontobel Research | |
| 24.04.12 | Novartis buy | WestLB AG | |
| 24.04.12 | Novartis halten | Independent Research GmbH | |
| 24.04.12 | Novartis buy | Sarasin Research | |
Werbung
Werbung